Effects of tyrosine kinase inhibitor-masitinib mesylate on canine mammary tumour cell lines
Authors
Fulya Ustun-Alkan
Department of Pharmacology and Toxicology, Istanbul, Turkey
Tülay Bakırel
Department of Pharmacology and Toxicology, Istanbul, Turkey
Oya Üstüner
Department of Pharmacology and Toxicology, Istanbul, Turkey
Ceren Anlas
Department of Pharmacology and Toxicology, Istanbul, Turkey
Suzan Cinar
Department of Immunology, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey
Funda Yıldırım
Department of Pathology, Faculty of Veterinary Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey
Aydın Gürel
Department of Pathology, Faculty of Veterinary Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey
DOI: https://doi.org/10.2478/jvetres-2021-042 | Journal eISSN: 2450-8608
Language: English
Page range: 351 - 359
Submitted on: Feb 5, 2021
Accepted on: Jul 5, 2021
Published on: Jul 24, 2021
Published by: National Veterinary Research Institute in Pulawy
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2021 Fulya Ustun-Alkan, Tülay Bakırel, Oya Üstüner, Ceren Anlas, Suzan Cinar, Funda Yıldırım, Aydın Gürel, published by National Veterinary Research Institute in Pulawy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.